Problems in the conduct and analysis of randomized clinical trials. Are we getting the right answers to the wrong

L Rabeneck1, C M Viscoli, R I Horwitz

  • 1Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510.

Insights

Randomized clinical trials (RCTs) face challenges during conduct, impacting results analysis. New methods are needed to balance trial validity with clinical relevance for accurate therapeutic evaluation.

Area of Science:

  • Clinical Medicine
  • Biostatistics
  • Research Methodology

Background:

  • Randomized clinical trials (RCTs) are the gold standard for evaluating medical therapies.
  • Methodological challenges arise during RCT conduct, affecting result analysis.
  • Key issues include deviations from intended treatment and incomplete outcome ascertainment.

Purpose of the Study:

  • To examine current analytical strategies for handling RCT conduct problems.
  • To assess how these strategies can alter research focus and compromise relevant questions.
  • To advocate for new design and analysis methods ensuring both validity and clinical pertinence.

Main Methods:

  • Review of existing analytical strategies for RCTs.
  • Analysis of how common issues (treatment changes, outcome ascertainment failures) impact trial interpretation.
  • Conceptual framework development for balancing validity and clinical relevance.

Main Results:

  • Current analytic strategies may inadvertently shift research focus away from the primary clinical question.
  • These strategies can lead to trials that are methodologically sound but clinically irrelevant.
  • The identified issues pose significant challenges to the interpretation of therapeutic effectiveness.

Conclusions:

  • Addressing conduct-related problems in RCTs requires innovative analytical approaches.
  • New methods must be developed to maintain the scientific rigor and clinical applicability of trial findings.
  • Balancing validity and clinical pertinence is crucial for advancing evidence-based medicine.

Related Concept Videos

Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...